ClinicalTrials.gg
Not yet recruitingNCT07580274Updated May 12, 2026

Effect of Early vs Late Water Exposure After Cutaneous Surgery

An interventional study of Care as usual and Care as usual in Surgical Site Infection (SSI), sponsored by Pak Emirates Military Hospital. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-05-12.

Sponsored by Pak Emirates Military Hospital · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Sex
All
01

Study summary

This randomized controlled trial aims to compare the effect of early versus delayed water exposure after cutaneous surgeries on the incidence of surgical site infections. Patients undergoing elective cutaneous surgical procedures will be randomly assigned to either early postoperative water exposure within 48 hours or delayed exposure after 7 days. Wound outcomes will be assessed using the Southampton Wound Grading System during follow-up visits. The study seeks to determine whether early water exposure is safe and whether it influences postoperative wound healing and infection rates.

02

Conditions studied

  • Surgical Site Infection (SSI)

Keywords

  • Cutaneous surgery
  • Surgical wound infection
  • Early water exposure
  • Post operative wound care
03

In context

Surgical Wound Infection

747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.

This study's planned enrollment of 82 is below the median of 200 across 583 interventional studies indexed under Surgical Wound Infection.

Browse Surgical Wound Infection studies →

Lead sponsor

Pak Emirates Military Hospital is the lead sponsor of 24 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing elective surgical procedures, such as excision of benign or malignant skin lesions, skin grafts, and skin .

Exclusion criteria

Exclusion Criteria:

  • 1.Patients on anti-coagulants.

    2.Compromised immune systems e.g. pregnancy, diabetes, therapies.

    3.Wounds that are located in areas with significant movements (e.g. joints) or that are highly prone to external contaminants (e.g. mucosal surfaces) which might bias result.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
82 participants (estimated)

Study arms

  • Experimental
    Early Water Exposure Group

    Participants will be allowed early postoperative wound exposure to water after cutaneous surgery and will be monitored for wound infection and healing outcomes.

    Behavioral: Care as usual

  • Active comparator
    Standard Wound Care Group

    Participants will follow conventional postoperative wound care instructions with delayed water exposure after cutaneous surgery.

    Behavioral: Care as usual

Interventions

  • BehavioralCare as usual

    Participants will be allowed early exposure of the postoperative wound to water following cutaneous surgery according to the study protocol.

    Also known as: Early Post operative Wound care

  • BehavioralCare as usual

    Participants will follow conventional postoperative wound care instructions with delayed exposure of the surgical wound to water.

    Also known as: Standard Post operative wound care

06

What researchers measure

Primary outcomes

  1. Postoperative Surgical Site Infection

    Assessment of the frequency of surgical site infection following cutaneous surgery in participants receiving early versus delayed postoperative water exposure.

    Time frame: 14 days postoperative

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Dec 2026, 6 months later.

Of 202 non-industry interventional studies with no phase under Surgical Wound Infection, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's planned 6 months is below that.

Counting every sponsor, half of 209 studies reached it within 24 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2026
First posted
May 12, 2026
StartEst.
Jun 1, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 1, 2026
Last update
May 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07580274
Lead sponsor
Pak Emirates Military Hospital
Responsible party
Saba Khan (Resident dermatology, Pak Emirates Military Hospital) — Principal investigator
First posted
May 12, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
May 12, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion